122 related articles for article (PubMed ID: 25019499)
21. Surfactants and experimental irritant contact dermatitis.
Effendy I; Maibach HI
Contact Dermatitis; 1995 Oct; 33(4):217-25. PubMed ID: 8654070
[TBL] [Abstract][Full Text] [Related]
22. Eye irritation of low-irritant cosmetic formulations: correlation of in vitro results with clinical data and product composition.
Debbasch C; Ebenhahn C; Dami N; Pericoi M; Van den Berghe C; Cottin M; Nohynek GJ
Food Chem Toxicol; 2005 Jan; 43(1):155-65. PubMed ID: 15582208
[TBL] [Abstract][Full Text] [Related]
23. Toxicologic screening of some surfactants using modern in vivo bioassays.
Ardelean S; Feflea S; Ionescu D; Năstase V; Dehelean CA
Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):251-8. PubMed ID: 21682193
[TBL] [Abstract][Full Text] [Related]
24. Assessment of primary eye and skin irritants by in vitro cytotoxicity and phototoxicity models: an in vitro approach of new arginine-based surfactant-induced irritation.
Benavides T; Mitjans M; Martínez V; Clapés P; Infante MR; Clothier RH; Vinardell MP
Toxicology; 2004 May; 197(3):229-37. PubMed ID: 15033545
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of an in vitro cell toxicity test using rabbit corneal cells to predict the eye irritation potential of surfactants.
North-Root H; Yackovich F; Demetrulias J; Gacula M; Heinze JE
Toxicol Lett; 1982 Dec; 14(3-4):207-12. PubMed ID: 7167981
[TBL] [Abstract][Full Text] [Related]
26. A QSAR model for the eye irritation of cationic surfactants.
Patlewicz GY; Rodford RA; Ellis G; Barratt MD
Toxicol In Vitro; 2000 Feb; 14(1):79-84. PubMed ID: 10699364
[TBL] [Abstract][Full Text] [Related]
27. Assessment of the potential skin irritation of lysine-derivative anionic surfactants using mouse fibroblasts and human keratinocytes as an alternative to animal testing.
Sanchez L; Mitjans M; Infante MR; Vinardell MP
Pharm Res; 2004 Sep; 21(9):1637-41. PubMed ID: 15497690
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of surfactant cytotoxicity potential by primary cultures of ocular tissues: I. Characterization of rabbit corneal epithelial cells and initial injury and delayed toxicity studies.
Grant RL; Yao C; Gabaldon D; Acosta D
Toxicology; 1992 Nov; 76(2):153-76. PubMed ID: 1281345
[TBL] [Abstract][Full Text] [Related]
29. Area and depth of surfactant-induced corneal injury correlates with cell death.
Jester JV; Li HF; Petroll WM; Parker RD; Cavanagh HD; Carr GJ; Smith B; Maurer JK
Invest Ophthalmol Vis Sci; 1998 May; 39(6):922-36. PubMed ID: 9579472
[TBL] [Abstract][Full Text] [Related]
30. Self-emulsifying O/W formulations of paclitaxel prepared from mixed nonionic surfactants.
Lo JT; Chen BH; Lee TM; Han J; Li JL
J Pharm Sci; 2010 May; 99(5):2320-32. PubMed ID: 19894274
[TBL] [Abstract][Full Text] [Related]
31. Prediction of the eye irritation potential of shampoos using the in vitro SIRC cell toxicity test.
North-Root H; Yackovich F; Demetrulias J; Gacula M; Heinze JE
Food Chem Toxicol; 1985 Feb; 23(2):271-3. PubMed ID: 4040076
[TBL] [Abstract][Full Text] [Related]
32. Utility of MTT assay in three-dimensional cultured human skin model as an alternative for draize skin irritation test: approach using diffusion law of irritant in skin and toxicokinetics-toxicodynamics correlation.
Watanabe T; Hasegawa T; Takahashi H; Ishibashi T; Itagaki H; Sugibayashi K
Pharm Res; 2002 May; 19(5):669-75. PubMed ID: 12069171
[TBL] [Abstract][Full Text] [Related]
33. Light microscopic comparison of surfactant-induced eye irritation in rabbits and rats at three hours and recovery/day 35.
Maurer JK; Parker RD
Toxicol Pathol; 1996; 24(4):403-11. PubMed ID: 8864182
[TBL] [Abstract][Full Text] [Related]
34. Ocular irritation: pathological changes occurring in the rat with surfactants of unknown irritancy.
Maurer JK; Parker RD; Carr GJ
Toxicol Pathol; 1998; 26(2):226-33. PubMed ID: 9547860
[TBL] [Abstract][Full Text] [Related]
35. Comparative studies on the ocular and dermal irritation potential of surfactants.
Mehling A; Kleber M; Hensen H
Food Chem Toxicol; 2007 May; 45(5):747-58. PubMed ID: 17169473
[TBL] [Abstract][Full Text] [Related]
36. Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles.
Leonardi A; Bucolo C; Romano GL; Platania CB; Drago F; Puglisi G; Pignatello R
Int J Pharm; 2014 Aug; 470(1-2):133-40. PubMed ID: 24792979
[TBL] [Abstract][Full Text] [Related]
37. Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants.
Furrer P; Plazonnet B; Mayer JM; Gurny R
Int J Pharm; 2000 Oct; 207(1-2):89-98. PubMed ID: 11036234
[TBL] [Abstract][Full Text] [Related]
38. Self-emulsifying oils for ocular drug delivery. II. In vitro release of indomethacin and hydrocortisone.
Czajkowska-Kośnik A; Sznitowska M; Mirkowska K
Acta Pol Pharm; 2012; 69(2):309-17. PubMed ID: 22568046
[TBL] [Abstract][Full Text] [Related]
39. Discrimination of the irritancy potential of surfactants in vitro by two cytotoxicity assays using normal human keratinocytes, HaCaT cells and 3T3 mouse fibroblasts: correlation with in vivo data from a soap chamber assay.
Korting HC; Herzinger T; Hartinger A; Kerscher M; Angerpointner T; Maibach HI
J Dermatol Sci; 1994 Apr; 7(2):119-29. PubMed ID: 8060913
[TBL] [Abstract][Full Text] [Related]
40. Validation of the red blood cell test system as in vitro assay for the rapid screening of irritation potential of surfactants.
Pape WJ; Pfannenbecker U; Hoppe U
Mol Toxicol; 1987-1988 Fall; 1(4):525-36. PubMed ID: 3509700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
